Shifa Biomedical Corporation products

LDLR is a cell-surface receptor that binds LDL-C and carries it into cells to the endosome for degradation and thus reduces the plasma level of LDL-C (Figure 1).  However, PCSK9 controls the degradation of the LDLR in the liver (Figure 1) and thereby contributes to cholesterol homeostasis.